Meg Hooton

R&D

Meg Hooton, President of IQVIA Biotech, leads the organisation, providing clinical development solutions for biotech and emerging biopharma clients.

News

With $81.3 million raised, Vogenx is the latest in a staggering summer of biotech IPOs. But the queue past this point looks thin.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.